abiraterone qilu 500 mg
qilu pharma spain s.l. - abirateronacetat - tablett, filmdrasjert - 500 mg
cinacalcet stada 30 mg
stada arzneimittel ag - cinacalcethydroklorid - tablett, filmdrasjert - 30 mg
cinacalcet stada 60 mg
stada arzneimittel ag - cinacalcethydroklorid - tablett, filmdrasjert - 60 mg
cinacalcet stada 90 mg
stada arzneimittel ag - cinacalcethydroklorid - tablett, filmdrasjert - 90 mg
zyrtec 10 mg
ucb nordic as - cetirizindihydroklorid - tablett, filmdrasjert - 10 mg
zilas 20 mg
menarini international o.l. sa - bilastin - tablett - 20 mg
letifend
leti pharma, s.l.u. - recombinant protein q from leishmania infantum mon-1 - inaktivert bakteriell vaksiner (inkludert mycoplasma, toxoid og klamydia) - hunder - for aktiv immunisering av hunder fra 6 måneder for å redusere risikoen for å utvikle et klinisk tilfelle av leishmaniasis.
tivicay
viiv healthcare bv - dolutegravir - hiv-infeksjoner - antivirale midler til systemisk bruk - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.
triumeq
viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv-infeksjoner - antivirale midler til systemisk bruk - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.
juluca
viiv healthcare b.v. - dolutegravir natrium, rilpivirine hydrochloride - hiv-infeksjoner - antivirale midler til systemisk bruk - juluca er angitt for behandling av humant immunsviktvirus type 1 (hiv-1) - infeksjon hos voksne som er virologically-undertrykket (hiv-1 rna.